TELA Bio share price logo

TELA Bio

NASDAQ: TELA

$0.81

-0.11

(-11.95%)

as on

TELA Bio Stock Performance

as on October 31, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.82
    $0.92
    downward going graph

    -1.22%

    Downside

    13.57%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.50
    $1.50
    downward going graph

    38.14%

    Downside

    85.16%

    Upside

    downward going graph

TELA Bio share price movements today

Previous Close
$0.92
Open
$0.92
Volume
511.8K
Market Cap
$44.1M
Day's Low - High
$0.82 - $0.92
52 Week Low - High
$0.50 - $1.50

TELA Bio Historical Returns

1 Month Return
-20 %
3 Month Return
+ 29.61 %
1 Year Return
-29.23 %
3 Year Return
-84.19 %
5 Year Return
-92.85 %

TELA Bio Stock Fundamentals & Key Indicators

Check TELA Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$44.1M

EPS (TTM)

-0.77

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.27

Industry PE ratio

-4.84

PEG Ratio

-0.03

EBITDA

-32.9M

Revenue (TTM)

79.9M

Profit Margin

67.81%

Return On Equity TTM

1248.13%

TELA Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of TELA Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
TELA Bio image
TELA Bio
Buy$44.1M-92.85%-1.2767.81%0.00%
Edwards Lifesciences image
Edwards Lifesciences
StrongBuy$52.9B-21.18%52.7577.98%0.00%
Medtronic image
Medtronic
Buy$121.2B-18.98%23.1766.69%3.02%
Stryker image
Stryker
StrongBuy$116.6B17.17%31.2465.17%1.16%
Abbott Laboratories image
Abbott Laboratories
StrongBuy$178.4B-20.37%38.1957.12%2.44%
See all

Stock Returns calculator for TELA Bio Stock including INR - Dollar returns

The TELA Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

TELA Bio investment value today

Current value as on today

₹66,689

Returns

-₹33,311

(-33.31%)

Returns from TELA Bio Stock

-₹37,685 (-37.68%)

Dollar Impact

₹4,373 (+4.37%)

Analyst Recommendation on TELA Bio Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for TELA Bio. Average target price of $1.9

TELA Bio Share Price Target

Get share price movements and forecasts by analysts on TELA Bio.

What analysts predicted

57.36%UPSIDE

Target Price

$1.9

Current Price

$0.8101

Analyzed by

2 Analysts

High

$2

Target

$1.90

Low

$2

TELA Bio target price $1.9, a slight upside of 57.36% compared to current price of $0.8101. According to 2 analysts rating.

Indian Investors' Interest in TELA Bio Stock

Search interest for TELA Bio Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

TELA Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
16
16
18
17
18
20
20
20
19
19
Gross Profit
11
11
12
11
12
14
13
13
12
13
Operating Income
-4
-11
-9
-8
-10
-9
-7
-6
-10
-9
EBITDA
-4
-11
-8
-7
-9
-8
-7
-7
-9
-8
Interest Expense
1
1
1
1
1
1
1
1
-2
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-12
-10
-9
-11
-9
-8
-8
-12
-11
Income Tax Expense
-
-
-
0
0
0
-
0
0
0
Net Income
-5
-12
-10
-9
-11
-9
-8
-9
-12
-11
Net Profit Margin
68.28%
68.81%
67.83%
63.58%
67.56%
69.84%
67.52%
65.91%
65.69%
72.28%

TELA Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
4
8
15
18
29
41
58
69
80
Gross Profit
2
2
9
11
18
27
40
46
54
Operating Income
-16
-17
-19
-25
-29
-39
-44
-34
-33
EBITDA
-16
-18
-18
-24
-29
-39
-40
-31
-32
Interest Expense
4
1
3
3
3
4
5
5
5
Depreciation
0
1
0
0
0
1
0
1
1
Income Before Tax
-21
-21
-22
-28
-33
-44
-46
-37
-38
Income Tax Expense
-
-
-
-
-
-
-
0
0
Net Income
-21
-21
-22
-28
-33
-44
-46
-37
-38
Net Profit Margin
59.65%
35.56%
60.03%
61.68%
63.85%
65.30%
68.62%
67.08%
67.69%

TELA Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-12
-10
-9
-11
-9
-8
-9
-12
-11
Operating Cash Flow
-14
-10
-8
-7
-9
-7
-5
-4
-11
-9
Investing Cash Flow
4
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
42
0
0
0
25
0
0
Change in Cash
-9
-10
-9
35
-9
-7
-5
21
-11
-9

TELA Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-21
-21
-22
-28
-33
-44
-46
-37
-38
Operating Cash Flow
-16
-19
-25
-24
-30
-40
-40
-41
-28
Investing Cash Flow
0
-1
-11
9
0
-1
0
4
0
Financing Cash Flow
26
27
65
44
0
40
46
43
25
Change in Cash
9
5
28
29
-30
-1
4
5
-1

Global Institutional Holdings in TELA Bio

Check out the Institutions with significant holdings in TELA Bio.

Funds
Holdings
VANGUARD INDEX FUNDS
3.41%
Vanguard
3.41%
Fidelity Concord Street Trust
0.72%
Jacob Funds Inc.
0.18%
World Funds Trust
0.14%
See all

TELA Bio News & Key Events

  • img

    Today's Timeline - 05 October

    Mon, 06:03 PM

    -

    TELA Bio receives FDA 510(k) clearance for Liora Monofilament Scaffold, enhancing its soft-tissue reconstruction portfolio.

Insights on TELA Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -12.27M → -11.26M (in $), with an average increase of 9.0% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 19.05M → 19.29M (in $), with an average increase of 1.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 14.5% return, outperforming this stock by 39.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 44.1% return, outperforming this stock by 128.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TELA stock has moved down by -6.3%

About TELA Bio

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
OrganisationTELA Bio
Headquarters1 Great Valley Parkway, Malvern, PA, 19355, US
IndustryMedical - Devices
CEOHeather Getz

Key Management of TELA Bio

Name

Title

Mr. Paul Talmo

Chief Technology Officer

Mr. D. Taylor Ocasio

General Counsel & Corporate Secretary

Mr. Jim Hagen

Senior VP of Strategic Commercial Operations & Marketing

Ms. Jennifer Lou Armstrong

Senior Vice President of Human Resources

Mr. Gregory A. Firestone

Chief Business Officer

Mr. Michael Leonard

Senior Vice President of Technical Operations

Mr. Jeffrey Blizard

President

Ms. Heather C. Getz CPA, M.B.A.

CEO, Principal Financial Officer & Director

Ms. Megan Smeykal

VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer

Dr. Howard N. Langstein

Chief Medical Officer

FAQs

What is TELA Bio share price today?

TELA Bio share price today is $0.81 as on at the close of the market. TELA Bio share today touched a day high of $0.92 and a low of $0.82.

What is the 52 week high and 52 week low for TELA Bio share?

TELA Bio share touched a 52 week high of $1.50 on and a 52 week low of $0.50 on . TELA Bio stock price today i.e. is closed at $0.81,which is 45.99% down from its 52 week high and 61.66% up from its 52 week low.

What is TELA Bio's market capitalisation today?

TELA Bio market capitalisation is $0.00T as on .

How to invest in TELA Bio Stock (TELA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for TELA Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy TELA Bio Stock (TELA) from India?

Indian investors can start investing in TELA Bio (TELA) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in TELA Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on TELA Bio share’s latest price of $0.81 as on October 31, 2026 at 8:46 am IST, you will get 12.3442 shares of TELA Bio. Learn more about fractional shares .

What are the returns that TELA Bio has given to Indian investors in the last 5 years?

TELA Bio stock has given -92.85% share price returns and 27.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?